½ÃÀ庸°í¼­
»óǰÄÚµå
1389183

¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : À¯Çüº°, ¾ç½Äº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Teledermatology Market Size Study & Forecast, by Type (Products, Services), by Modality (Store-and-forward, Real-time, Others), by End-user (Healthcare Facilities, Homecare), and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¿ø°Ý ÇǺΰú ½ÃÀåÀº 2022³â ¾à 80¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ÀÎ 2023-2030³â°£ µ¿¾È 16.3% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ø°Ý ÇǺΰúÇÐÀº ¿ø°Ý ÀÇ·áÀÇ ÇÑ Àü¹® ºÐ¾ß·Î È­»óȸÀÇ, À̹ÌÁö °øÀ¯¿Í °°Àº Åë½Å µµ±¸¸¦ ÀÌ¿ëÇØ ¿ø°ÝÀ¸·Î ÇǺΰú Ä¡·á¿Í ÁøÂûÀ» ÇÏ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÇǺΰúÇÐÀº ÇǺΠÁúȯ, °¨¿° ¹× ¹Ì¿ë ¹®Á¦¸¦ ½Äº°Çϰí Ä¡·áÇÏ´Â µ¥ ÁßÁ¡À» µÎ´Â ÀÇÇÐ ºÐ¾ßÀÔ´Ï´Ù. ÇǺΰú ÀÇ»çµéÀº ¿ø°Ý ÇǺΰú(¿ø°Ý ÇǺΰú)¸¦ ÅëÇØ º´¿ø¿¡ °¥ ¼ö ¾ø°Å³ª ¿ø°Ý Áø·áÀÇ Æí¸®ÇÔÀ» ¼±È£ÇÏ´Â °í°´µé¿¡°Ô Àü¹® Áö½ÄÀ» Á¦°øÇÕ´Ï´Ù. Æí¸®Çϰí Á¢±ÙÇϱ⠽¬¿î ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¿ø°Ý ÇǺΰú ¼­ºñ½º¿¡ ´ëÇÑ »óȯ Áõ°¡, ÇǺΰú ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä ±ÞÁõ, ÀÎÅͳݰú ½º¸¶Æ®ÆùÀÇ ±Þ¼ÓÇÑ º¸±Þ µîÀÌ ¼¼°è ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÇǺξÏ, ½ÀÁø, °Ç¼± µî ´Ù¾çÇÑ ÇǺΠÁúȯÀÇ ¹ß»ý·ü Áõ°¡´Â ÃßÁ¤ ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀÇ Ã˸ÅÁ¦ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. 2022³â ¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH)ÀÇ Á¶»ç¿¡ µû¸£¸é, À¯·´¿¡¼­ 9,400¸¸ ¸íÀÌ °¡·Á¿òÁõ, È«Á¶, °ÇÁ¶ÇÔ°ú °°Àº ºÒÄèÇÑ ÇǺΠ°¨°¢À» °æÇèÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. À» °æÇèÇϰí ÀÖ½À´Ï´Ù. °¡Àå ÈçÇÑ ÁúȯÀº ¾ÆÅäÇÇ ÇǺο° ¶Ç´Â ½ÀÁø(5.5%), Áø±Õ¼º ÇǺΠ°¨¿°(8.9%), ¿©µå¸§(5.4%)À¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¿©µå¸§, Å»¸ðÁõ, ÁÖ»ç, ½ÀÁøÀº ¿©¼º¿¡°Ô, °Ç¼±°ú ¼ºº´Àº ³²¼º¿¡°Ô ´õ ¸¹¾Ò½À´Ï´Ù. ÀÌ¿¡ µû¶ó Á¤±âÀûÀÎ ÇǺΠ°ËÁø°ú Àû½Ã¿¡ ÇǺΰú Áø·á¸¦ ¹Þ´Â °ÍÀÌ Áß¿äÇÏ´Ù´Â ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¼¼°è ¿ø°Ý ÇǺΰú ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Åë½Å ±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀü°ú ÀÇ·á ºÐ¾ß¿¡¼­ ÀÚµ¿È­ ±â¼úÀÇ »ç¿ë Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ´Ù¾çÇÑ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù. ±×·¯³ª À̹ÌÁö ǰÁú°ú ÇØ¼®, Á¦ÇÑµÈ ½Åü °Ë»ç µîÀº 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¼¼°è ¿ø°Ý ÇǺΰú ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â Æí¸®Çϰí Á¢±ÙÇϱ⠽¬¿î ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¿ø°Ý Áø·á¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, DermatologistsOnCall ¹× MDLive¿Í °°Àº ¿©·¯ ´ëÇü ±â¾÷ÀÇ Á¸Àç·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¾çÇÑ ÇǺΠÁúȯ »ç·Ê Áõ°¡, ÀÎÅÍ³Ý ¹× ½º¸¶Æ®ÆùÀÇ º¸±Þ Áõ°¡, Á¤ºÎÀÇ ¿ø°Ý ÀÇ·á °³Çõ ¹× äÅÃÀº ÀÌ Áö¿ª Àüü ½ÃÀå ¼ö¿ä¸¦ Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³âµ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ Á¤ÀÇÇϰí ÇâÈÄ ¸î ³âµ¿¾ÈÀÇ °¡Ä¡¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • ¾÷°è ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó³âµµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå ¿ªÇÐ

  • ¿ø°Ý ÇǺΰú ½ÃÀå ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • ½ÃÀå ±âȸ

Á¦4Àå ¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå : À¯Çüº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå : À¯Çüº°, ½ÇÀû¡¤°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå : À¯Çüº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ¿ø°Ý ÇǺΰú ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • Á¦Ç°
    • ¼­ºñ½º

Á¦6Àå ¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå : ¸ð´Þ¸®Æ¼º°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå : ¸ð´Þ¸®Æ¼º°, ½ÇÀû¡¤°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå : ¸ð´Þ¸®Æ¼º°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ¿ø°Ý ÇǺΰú ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • Store-and-forward (Asynchronous)
    • Real-time (Synchronous)
    • ±âŸ

Á¦7Àå ¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû¡¤°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ¿ø°Ý ÇǺΰú ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ÀÇ·á½Ã¼³
    • ÀçÅÃÄ¡·á

Á¦8Àå ¼¼°èÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • ¿ø°Ý ÇǺΰú ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • À¯Çüº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ¸ð´Þ¸®Æ¼º°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ÃÖÁ¾»ç¿ëÀÚº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¿ø°Ý ÇǺΰú ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • 3Gen DermLite(¹Ì±¹)
    • Ksyos(³×´ú¶õµå)
    • MetaOptima Technology Inc.(ij³ª´Ù)
    • 3Derm Systems Inc.(¹Ì±¹)
    • VigNet Inc.(¹Ì±¹)
    • Maple(ij³ª´Ù)
    • MDLIVE Inc.(¹Ì±¹)
    • CureSkin(Àεµ)
    • Ping an Good Doctor(Áß±¹)
    • FirstDerm(¹Ì±¹)

Á¦10Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
LSH 23.12.13

Global Teledermatology Market is valued at approximately USD 8.06 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 16.3% over the forecast period 2023-2030. Teledermatology is a specialized field of telemedicine that includes providing dermatological care and consultation remotely utilizing communication tools such as video conferencing and image sharing. Dermatology is a field of medicine that focuses on identifying and treating illnesses, infections, and aesthetic problems of the skin. Through Teledermatology, dermatologists provide their expertise to clients who are unable to go to a clinic or who prefer the ease of remote consultations. Factors such as rising demand for convenient and accessible healthcare, increasing reimbursement for Teledermatology services, a surge in demand for dermatological services, and rapid penetration of the internet and smartphones are primarily driving the market growth globally.

The rise in incidences of various skin conditions such as skin cancer, eczema, and psoriasis is acting as a catalyzing factor for the market growth during the estimated period. Teleconsultation offers quicker, higher-quality dermatological treatment, and it is considered a solution to lessen the effects of the rising consultation rate and dermatologist scarcity. According to National Institutes of Health (NIH) study in 2022, 94 million individuals in Europe experience uncomfortable skin sensations including itching, burning, or dryness. The most prevalent disorders were atopic dermatitis or eczema (5.5%), fungal skin infections (8.9%), and acne (5.4%). Women are more prone to experience acne, alopecia, rosacea, and eczema, whereas men are more likely to get psoriasis and STDs. As a result, this has raised awareness about the importance of regular skin checks and timely dermatological consultations, which boosted the global teledermatology market growth. Moreover, the rapid advancements in telecommunications technology, as well as the increasing use of automation technologies in the healthcare sector present various lucrative opportunities over the forecast years. However, the image quality and interpretation, along with the limited physical examination are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Teledermatology Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing demand for convenient and accessible healthcare, rising inclination towards teleconsultations, and the presence of several large-scale players, such as DermatologistsOnCall, and MDLive. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The rise in cases of various skin disorders, increasing proliferation of the internet and smartphones, as well as reforms and adoption of telehealth by governments are significantly propelling the market demand across the region.

Major market players included in this report are:

  • 3Gen DermLite (U.S.)
  • Ksyos (Netherlands)
  • MetaOptima Technology Inc. (Canada)
  • 3Derm Systems Inc. (U.S.)
  • VigNet Inc. (U.S.)
  • Maple (Canada)
  • MDLIVE Inc. (U.S.)
  • CureSkin (India)
  • Ping an Healthcare And Technology Company Limited (China)
  • FirstDerm (U.S.)

Recent Developments in the Market:

  • In March 2022, Cheshire and Merseyside ICS introduced a new teledermatology technology package. It is part of an initiative to make dermatological patient referrals and triage more efficient.
  • In February 2022, Ro announced the opening of Ro Derm. It is a teledermatology service that links customers with a U.S.-licensed healthcare provider to offer a consultation and prescription therapy that is adapted to the needs of the patient.
  • In February 2022, Doxy.me and MedRegis announced the company's partnership to improve the availability and cost-effectiveness of outpatient healthcare services for the people of Barbados.

Global Teledermatology Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Modality, End-user, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Products
  • Services

By Modality:

  • Store-and-forward (Asynchronous)
  • Real-time (Synchronous)
  • Others

By End-user:

  • Healthcare Facilities
  • Homecare

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Teledermatology Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Teledermatology Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Teledermatology Market, by Modality, 2020-2030 (USD Billion)
    • 1.2.4. Teledermatology Market, by End-user, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Teledermatology Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Teledermatology Market Dynamics

  • 3.1. Teledermatology Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Surge in demand for dermatological services
      • 3.1.1.2. Rise in incidences of various skin conditions
    • 3.1.2. Market Challenges
      • 3.1.2.1. Image quality and interpretation
      • 3.1.2.2. Limited physical examination
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rapid advancements in telecommunications technology
      • 3.1.3.2. Increasing use of automation technologies in the healthcare sector

Chapter 4. Global Teledermatology Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Teledermatology Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Teledermatology Market by Type, Performance - Potential Analysis
  • 5.3. Global Teledermatology Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Teledermatology Market, Sub Segment Analysis
    • 5.4.1. Products
    • 5.4.2. Services

Chapter 6. Global Teledermatology Market, by Modality

  • 6.1. Market Snapshot
  • 6.2. Global Teledermatology Market by Modality, Performance - Potential Analysis
  • 6.3. Global Teledermatology Market Estimates & Forecasts by Modality 2020-2030 (USD Billion)
  • 6.4. Teledermatology Market, Sub Segment Analysis
    • 6.4.1. Store-and-forward (Asynchronous)
    • 6.4.2. Real-time (Synchronous)
    • 6.4.3. Others

Chapter 7. Global Teledermatology Market, by End-user

  • 7.1. Market Snapshot
  • 7.2. Global Teledermatology Market by End-user, Performance - Potential Analysis
  • 7.3. Global Teledermatology Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
  • 7.4. Teledermatology Market, Sub Segment Analysis
    • 7.4.1. Healthcare Facilities
    • 7.4.2. Homecare

Chapter 8. Global Teledermatology Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Teledermatology Market, Regional Market Snapshot
  • 8.4. North America Teledermatology Market
    • 8.4.1. U.S. Teledermatology Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Modality breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End-user breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Teledermatology Market
  • 8.5. Europe Teledermatology Market Snapshot
    • 8.5.1. U.K. Teledermatology Market
    • 8.5.2. Germany Teledermatology Market
    • 8.5.3. France Teledermatology Market
    • 8.5.4. Spain Teledermatology Market
    • 8.5.5. Italy Teledermatology Market
    • 8.5.6. Rest of Europe Teledermatology Market
  • 8.6. Asia-Pacific Teledermatology Market Snapshot
    • 8.6.1. China Teledermatology Market
    • 8.6.2. India Teledermatology Market
    • 8.6.3. Japan Teledermatology Market
    • 8.6.4. Australia Teledermatology Market
    • 8.6.5. South Korea Teledermatology Market
    • 8.6.6. Rest of Asia Pacific Teledermatology Market
  • 8.7. Latin America Teledermatology Market Snapshot
    • 8.7.1. Brazil Teledermatology Market
    • 8.7.2. Mexico Teledermatology Market
  • 8.8. Middle East & Africa Teledermatology Market
    • 8.8.1. Saudi Arabia Teledermatology Market
    • 8.8.2. South Africa Teledermatology Market
    • 8.8.3. Rest of Middle East & Africa Teledermatology Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. 3Gen DermLite (U.S.)
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Ksyos (Netherlands)
    • 9.3.3. MetaOptima Technology Inc. (Canada)
    • 9.3.4. 3Derm Systems Inc. (U.S.)
    • 9.3.5. VigNet Inc. (U.S.)
    • 9.3.6. Maple (Canada)
    • 9.3.7. MDLIVE Inc. (U.S.)
    • 9.3.8. CureSkin (India)
    • 9.3.9. Ping an Good Doctor (China)
    • 9.3.10. FirstDerm (U.S.)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦